RC Schuit
RC Schuit
VU medical center
Geverifieerd e-mailadres voor vumc.nl
Geciteerd door
Geciteerd door
Δ9-tetrahydrocannabinol induces dopamine release in the human striatum
MG Bossong, BN Van Berckel, R Boellaard, L Zuurman, RC Schuit, ...
Neuropsychopharmacology 34 (3), 759-766, 2009
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
DME van Assema, M Lubberink, M Bauer, WM van der Flier, RC Schuit, ...
Brain 135 (1), 181-189, 2012
P-glycoprotein function at the blood–brain barrier: effects of age and gender
DME van Assema, M Lubberink, R Boellaard, RC Schuit, AD Windhorst, ...
Molecular imaging and biology 14, 771-776, 2012
PET imaging of αvβ3 integrin expression in tumours with 68Ga-labelled mono-, di- and tetrameric RGD peptides
I Dijkgraaf, CB Yim, GM Franssen, RC Schuit, G Luurtsema, S Liu, ...
European journal of nuclear medicine and molecular imaging 38, 128-137, 2011
Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status
I Bahce, EF Smit, M Lubberink, AAM van der Veldt, M Yaqub, ...
Clinical Cancer Research 19 (1), 183-193, 2013
Myoclonus‐dystonia: significance of large SGCE deletions
A Grünewald, A Djarmati, K Lohmann‐Hedrich, K Farrell, JA Zeller, ...
Human mutation 29 (2), 331-332, 2008
Evaluation of (R)-[11C] verapamil as PET tracer of P-glycoprotein function in the blood–brain barrier: kinetics and metabolism in the rat
G Luurtsema, CFM Molthoff, RC Schuit, AD Windhorst, AA Lammertsma, ...
Nuclear medicine and biology 32 (1), 87-93, 2005
Quantification of [18F]DPA-714 Binding in the Human Brain: Initial Studies in Healthy Controls and Alzheimer'S Disease Patients
SSV Golla, R Boellaard, V Oikonen, A Hoffmann, BNM Van Berckel, ...
Journal of Cerebral Blood Flow & Metabolism 35 (5), 766-772, 2015
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
CW Menke-van der Houven, EC Gootjes, MC Huisman, DJ Vugts, C Roth, ...
Oncotarget 6 (30), 30384, 2015
Blood–brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene
DME van Assema, M Lubberink, P Rizzu, JC van Swieten, RC Schuit, ...
EJNMMI research 2, 1-6, 2012
Evaluation of [11C] laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats
G Luurtsema, RC Schuit, RP Klok, J Verbeek, JE Leysen, ...
Nuclear medicine and biology 36 (6), 643-649, 2009
Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C] A‐740003 as a novel tracer of neuroinflammation
B Janssen, DJ Vugts, U Funke, A Spaans, RC Schuit, E Kooijman, ...
Journal of Labelled Compounds and Radiopharmaceuticals 57 (8), 509-516, 2014
Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation
B Janssen, DJ Vugts, SM Wilkinson, D Ory, S Chalon, JJM Hoozemans, ...
Scientific reports 8 (1), 6580, 2018
Quantification of PD-L1 expression with 18F-BMS-986192 PET/CT in patients with advanced-stage non–small cell lung cancer
MC Huisman, ALN Niemeijer, AD Windhorst, RC Schuit, D Leung, ...
Journal of Nuclear Medicine 61 (10), 1455-1460, 2020
Rapid and quantitative analysis of unconjugated C27 bile acids in plasma and blood samples by tandem mass spectrometry
DW Johnson, HJ Ten Brink, RC Schuit, C Jakobs
Journal of lipid research 42 (1), 9-16, 2001
In vivo tau pathology is associated with synaptic loss and altered synaptic function
EM Coomans, DN Schoonhoven, H Tuncel, SCJ Verfaillie, EE Wolters, ...
Alzheimer's research & therapy 13, 1-13, 2021
Array CGH in molecular diagnosis of mental retardation—a study of 150 finnish patients
L Siggberg, S Ala‐Mello, E Jaakkola, E Kuusinen, R Schuit, J Kohlhase, ...
American Journal of Medical Genetics Part A 152 (6), 1398-1410, 2010
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
MHJ Hagens, SSV Golla, B Janssen, DJ Vugts, W Beaino, AD Windhorst, ...
European journal of nuclear medicine and molecular imaging 47, 379-389, 2020
In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET
MHJ Hagens, SV Golla, MT Wijburg, M Yaqub, D Heijtel, MD Steenwijk, ...
Journal of neuroinflammation 15, 1-10, 2018
Development of [18F] afatinib as new TKI-PET tracer for EGFR positive tumors
P Slobbe, AD Windhorst, M Stigter-van Walsum, RC Schuit, EF Smit, ...
Nuclear medicine and biology 41 (9), 749-757, 2014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20